Capital Markets Day 2023
Ipsen plans to host a capital-markets day, starting at 12.30 pm GMT on 7 December 2023, at The Brewery, London. In-person attendance is by invitation only.
The event will be webcast live.
WEBCAST REGISTRATION
The event will be broadcast live via a webcast, with the opportunity for online participants to ask questions in real-time. Register for access to join the event. Additionally, a replay of the event will be made available for later viewing.
Speakers
As well as an opportunity to meet management, the event will focus on R&D strategy, pipeline opportunities, the drivers of key on-market medicines, as well as a mid-term outlook.
IPSEN IN BRIEF
Our vision is to be a leading global mid-sized biopharmaceutical company with a focus on transformative medicines in Oncology, Rare Disease and Neuroscience.
Discover Ipsen in two pages: our medicines and key figures, our objectives and our strategy.
Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to: paula.brooks@ipsen.com
Your dedicated contacts
-
Craig Marks
Vice President, Investor Relations
-
-
Nicolas Bogler
Senior Manager, Investor Relations
-
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
Ipsen’s mission to accelerate innovation in oncology
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
Ipsen is officially recognized as a great place to work worldwide
2023 year to date and third-quarter sales results
A strong first half of 2023
Winner of Ipsen’s golden ticket announced as newest resident of Biolabs Hôtel Dieu
David Loew, Philippe Lopes Fernandes inaugurate Biolabs – Hôtel Dieu
Ipsen’s partnership with Marengo
